Literature DB >> 20028897

Clinical utility of PET/CT in lymphoma.

Carmel G Cronin1, Ronan Swords, Mylene T Truong, Chitra Viswanathan, Eric Rohren, Francis J Giles, Michael O'Dwyer, John F Bruzzi.   

Abstract

OBJECTIVE: The purpose of this review is to assist interpreting radiologists in becoming familiar with the role of PET/CT in baseline staging and therapeutic response assessment in the management of lymphoma, in becoming aware of imaging pitfalls, and in understanding the natural behavior of lymphoma and the therapeutic options.
CONCLUSION: Therapeutic strategies for the management of lymphoma are constantly being refined to improve long-term survival with the lowest risk of toxicity to the patient. PET/CT is accurate for baseline staging and yields important prognostic information for determining the most appropriate initial treatment. Used for evaluation of treatment response, PET/CT can depict residual viable malignant lesions with greater accuracy than can other imaging techniques. The findings thereby influence decisions about the need for additional or alternative treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20028897     DOI: 10.2214/AJR.09.2637

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  33 in total

1.  Role of [18F]-FDG-PET/MDCT in evaluating early response in patients with Hodgkin's lymphoma.

Authors:  A Orlacchio; O Schillaci; E Gaspari; F Della Gatta; R Danieli; F Bolacchi; C Ragano Caracciolo; A Mancini; G Simonetti
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

2.  A case of early stage lung cancer detected by repeated cancer screening with positron emission tomography.

Authors:  Ikuko Sakata; Yuichi Ozeki; Katsumi Tamura; Jiro Ishida; Shinsuke Aida; Yoshiyuki Abe
Journal:  Oncol Lett       Date:  2011-11-22       Impact factor: 2.967

3.  Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide.

Authors:  Ali Azhdarinia; Nathaniel Wilganowski; Holly Robinson; Pradip Ghosh; Sunkuk Kwon; Zawaunyka W Lazard; Alan R Davis; Elizabeth Olmsted-Davis; Eva M Sevick-Muraca
Journal:  Bioorg Med Chem       Date:  2011-05-06       Impact factor: 3.641

4.  Diagnosis of diffuse spleen involvement in haematological malignancies using a spleen-to-liver attenuation ratio on contrast-enhanced CT images.

Authors:  Christian Philipp Reinert; Clemens Hinterleitner; Jan Fritz; Konstantin Nikolaou; Marius Horger
Journal:  Eur Radiol       Date:  2018-06-18       Impact factor: 5.315

5.  Predictive value of pretreatment positron emission tomography/computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma.

Authors:  Bing Bai; Hui-Qiang Huang; Qi-Chun Cai; Wei Fan; Xiao-Xiao Wang; Xu Zhang; Ze-Xiao Lin; Yan Gao; Yun-Fei Xia; Ying Guo; Qing-Qing Cai; Wen-Qi Jiang; Tong-Yu Lin
Journal:  Med Oncol       Date:  2013-01-18       Impact factor: 3.064

6.  Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma.

Authors:  Bouthaina S Dabaja; Jack Phan; Osama Mawlawi; L Jeffrey Medeiros; Carol Etzel; Fu-Wen Liang; Donald Podoloff; Yasuhiro Oki; Fredrick B Hagemeister; Hubert Chuang; Luis E Fayad; Jason Robert Westin; Ferial Shihadeh; Pamela K Allen; Christine F Wogan; Maria A Rodriguez
Journal:  Leuk Lymphoma       Date:  2013-05-07

7.  Usefulness of (18)F-FDG positron emission tomography/computed tomography for the diagnosis of pyothorax-associated lymphoma: A report of three cases.

Authors:  Yoshiyuki Abe; Katsumi Tamura; Ikuko Sakata; Jiro Ishida; Isao Fukuba; Rokuro Matsuoka; Seiichiro Shimizu; Hiroshi Murakami; Kikuo Machida
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

8.  Unique intense uptake demonstrated by (18)F-FDG positron emission tomography/computed tomography in primary pancreatic lymphoma: A case report.

Authors:  Yoshiyuki Abe; Katsumi Tamura; Ikuko Sakata; Jiro Ishida; Masaya Mukai; Makoto Ohtaki; Masato Nakamura; Kikuo Machida
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

Review 9.  Utility of positron emission tomography/CT in the evaluation of small bowel pathology.

Authors:  C G Cronin; J Scott; A Kambadakone; O A Catalano; D Sahani; M A Blake; S McDermott
Journal:  Br J Radiol       Date:  2012-09       Impact factor: 3.039

Review 10.  [Hemato-oncological imaging : Importance of hybrid procedures].

Authors:  M E Mayerhoefer; A Haug
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.